[reaction: see text] Dirhodium caprolactamate [Rh2(cap)4] is an effective catalyst for benzylic oxidation with tert-butyl hydroperoxide (TBHP) under mild conditions. Sodium bicarbonate is the optimal base additive for substrate conversion. Benzylic carbonyl compounds are readily obtained, and a formal synthesis of palmarumycin CP2 using this methodology is described.
Elucidating the causes of congenital heart defects is made difficult by the complex morphogenesis of the mammalian heart, which takes place early in development, involves contributions from multiple germ layers, and is controlled by many genes. Here, we use a conditional/invertible genetic strategy to identify the cell lineage(s) responsible for the development of heart defects in a Nipbl-deficient mouse model of Cornelia de Lange Syndrome, in which global yet subtle transcriptional dysregulation leads to development of atrial septal defects (ASDs) at high frequency. Using an approach that allows for recombinase-mediated creation or rescue of Nipbl deficiency in different lineages, we uncover complex interactions between the cardiac mesoderm, endoderm, and the rest of the embryo, whereby the risk conferred by genetic abnormality in any one lineage is modified, in a surprisingly non-additive way, by the status of others. We argue that these results are best understood in the context of a model in which the risk of heart defects is associated with the adequacy of early progenitor cell populations relative to the sizes of the structures they must eventually form.
Dirhodium(II) caprolactamate exhibits optimal efficiency for the production of the tert-butylperoxy radical, which is a selective reagent for hydrogen atom abstraction. These oxidation reactions occur with aqueous tert-butyl hydroperoxide (TBHP) without rapid hydrolysis of the caprolactamate ligands on dirhodium. Allylic oxidations of enones yield the corresponding enedione in moderate to high yields, and applications include allylic oxidations of steroidal enones. Although methylene oxidation to a ketone is more effective, methyl oxidation to a carboxylic acid can also be achieved. The superior efficiency of dirhodium(II) caprolactamate as a catalyst for allylic oxidations by TBHP (mol % catalyst, % conversion) is described in comparative studies with other metal catalysts that are also reported to be effective for allylic oxidations. That different catalysts produce essentially the same mixture of products with the same relative yields suggests that the catalyst is not involved in product forming steps. Mechanistic implications arising from studies of allylic oxidation with enones provide new insights into factors that control product formation. A previously undisclosed disproportionation pathway, catalyzed by the tert-butoxy radical, of mixed peroxides for the formation of ketone products via allylic oxidation has been uncovered.
The dirhodium caprolactamate [Rh(2)(cap)(4)] catalyzed oxidation of secondary amines to imines by tert-butyl hydroperoxide (TBHP) occurs with high chemo- and regioselectivity.
Monodentate phosphoramidite ligands have been developed based on enantiopure 6,6-dimethylbiphenols with axial chirality. These chiral ligands are easy to prepare and flexible for modifications. The fine-tuning capability of these ligands plays a significant role in achieving high enantioselectivity in the asymmetric hydroformylation of allyl cyanide and the conjugate addition of diethylzinc to cycloalkenones. R ecently, chiral monodentate phosphorus ligands (phosphites, phosphoramidites, and phosphonites) have been attracting considerable interest for their use in catalytic asymmetric synthesis, because the chiral catalysts bearing these ligands have proven to be highly efficient in various asymmetric reactions. This is a previously univestigated wave in the design of chiral ligands, which makes a sharp contrast to almost three decades of predominance by C2 symmetrical bidentate phosphorus ligands for a variety of catalytic asymmetric transformations. This wave of designing simple and readily modifiable chiral structures, which are easy to synthesize, is fitting very well to the trendy and highly practical combinatorial approaches to the development of the most suitable chiral ligand for a particular catalytic asymmetric process of commercial value or academic interest. This approach is currently considered most practical rather than trying to develop a universal and almighty chiral ligand for different types of catalytic asymmetric transformations.Before the launch of our research program on the development of chiral monodentate phosphorus ligands based on enantiopure 2,2Ј-dihydroxy-6,6Ј-dimethylbiphenyls, by far, the most studied monodentate ligands were phosphites and phosphoramidites based on TADDOL (1) (1) BINOL (2) (2-4), a spirobiindanediol (3) (5), or an achiral biphenol (4) (6, 7) bearing a chiral or achiral secondary alcohol or amine (Fig. 1). These ligands have found a wide range of applications in metalcatalyzed asymmetric transformations such as hydrogenation (5, 8-10), 1,4-additions of dialkylzinc (11, 12) and boronic acids (13) to enones, hydrovinylation (14), hydrosilylation (15), intramolecular Heck reaction (16), hydroformylation (17), allylic alkylation (18, 19), amination (20), and etherification (21).We have been developing a previously uninvestigated class of chiral monodentate phosphite and phosphoramidite ligands, 5 and 6, from readily accessible enantiopure, axially chiral biphenyls ( Fig. 2) and have recently published the successful application of chiral monophosphite ligands 5 to the Rh(I)-catalyzed asymmetric hydrogenation of dimethyl itaconate (Fig. 2) (22).One of the salient and practical features of these chiral monophosphite ligands is the fine-tuning capability with modifiable substituents R 1 , R 2 , and R 3 in the formula 5. This fine-tuning capability of ligands 5 (phosphites) and 6 (phosphoramidites) is expected to play a crucial role in the application of these ligands to a variety of catalytic asymmetric reactions. In fact, we have demonstrated that the substituents (R 2 )...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.